These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23033840)

  • 41. N-terminal pro-B-type natriuretic Peptide predicts significant coronary artery lesion in the unstable angina patients with normal electrocardiogram, echocardiogram, and cardiac enzymes.
    Hong SN; Yoon NS; Ahn Y; Lim SY; Kim YS; Yun KH; Kang DK; Lee SH; Lee YS; Kim KH; Son IS; Hong YJ; Park HW; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
    Circ J; 2005 Dec; 69(12):1472-6. PubMed ID: 16308494
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk stratification in stable coronary artery disease: superiority of N-terminal pro B-type natriuretic peptide over high-sensitivity C-reactive protein, gamma-glutamyl transferase, and traditional risk factors.
    Bode E; Wuppinger T; Bode T; Alber H; Ulmer H; Pachinger O; Mair J
    Coron Artery Dis; 2012 Mar; 23(2):91-7. PubMed ID: 22157356
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High-sensitivity troponin T improves the prognostic value of N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: results from the LURIC Study.
    Ivandic BT; Spanuth E; Kleber M; Grammer TB; März W
    Clin Chem Lab Med; 2011 Jun; 49(6):1053-8. PubMed ID: 21574877
    [TBL] [Abstract][Full Text] [Related]  

  • 44. N-terminal pro-B-type natriuretic peptide level is depressed in patients with significant coronary artery disease who have high body mass index.
    Hong SN; Ahn Y; Yoon NS; Moon JY; Kim KH; Hong YJ; Park HW; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
    Int Heart J; 2008 Jul; 49(4):403-12. PubMed ID: 18753724
    [TBL] [Abstract][Full Text] [Related]  

  • 45. N-terminal pro-brain natriuretic peptide and abnormal brain aging: The AGES-Reykjavik Study.
    Sabayan B; van Buchem MA; de Craen AJ; Sigurdsson S; Zhang Q; Harris TB; Gudnason V; Arai AE; Launer LJ
    Neurology; 2015 Sep; 85(9):813-20. PubMed ID: 26231259
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Amino-terminal fragment of the prohormone brain-type natriuretic peptide in rheumatoid arthritis.
    Solus J; Chung CP; Oeser A; Avalos I; Gebretsadik T; Shintani A; Raggi P; Sokka T; Pincus T; Stein CM
    Arthritis Rheum; 2008 Sep; 58(9):2662-9. PubMed ID: 18759301
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical significance of N-terminal Pro-B-type natriuretic peptide (NT-proBNP) in hemodialysis patients.
    Helal I; Belhadj R; Mohseni A; Bazdeh L; Drissa H; Elyounsi F; Abdallah TB; Abdelmoula J; Kheder A
    Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):262-8. PubMed ID: 20228511
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Carbohydrate antigen-125 and N-terminal pro-brain natriuretic peptide levels: compared in heart-failure prognostication.
    Ordu S; Ozhan H; Alemdar R; Aydin M; Caglar O; Yuksel H; Kandis H
    Tex Heart Inst J; 2012; 39(1):30-5. PubMed ID: 22412224
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum N-terminal-pro-brain natriuretic peptide (NT-pro-BNP) and homocysteine levels in type 2 diabetic patients with asymptomatic left ventricular diastolic dysfunction.
    Görmüş U; Ozmen D; Ozmen B; Parildar Z; Ozdoğan O; Mutaf I; Bayindir O
    Diabetes Res Clin Pract; 2010 Jan; 87(1):51-6. PubMed ID: 19932518
    [TBL] [Abstract][Full Text] [Related]  

  • 50. N-terminal pro-brain natriuretic peptide could be a marker of subclinical atherosclerosis in patients with type 2 diabetes.
    Senmaru T; Fukui M; Tanaka M; Sakabe K; Ushigome E; Asano M; Yamazaki M; Hasegawa G; Nakamura N
    Heart Vessels; 2013 Mar; 28(2):151-6. PubMed ID: 22234513
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study.
    Daniels LB; Laughlin GA; Clopton P; Maisel AS; Barrett-Connor E
    J Am Coll Cardiol; 2008 Aug; 52(6):450-9. PubMed ID: 18672166
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Prediction of the risk of coronary arterial lesions in Kawasaki disease by N-terminal pro-brain natriuretic peptide].
    Huiling L; Yaping L; Xiufen H
    Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):300-3. PubMed ID: 26182507
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Polymorphisms in the B-type natriuretic peptide (BNP) gene are associated with NT-proBNP levels but not with diabetic nephropathy or mortality in type 1 diabetic patients.
    Lajer M; Tarnow L; Jorsal A; Parving HH
    Nephrol Dial Transplant; 2007 Nov; 22(11):3235-9. PubMed ID: 17567649
    [TBL] [Abstract][Full Text] [Related]  

  • 54. N-terminal pro-B-type natriuretic peptide concentrations predict the risk of cardiovascular adverse events from antiinflammatory drugs: a pilot trial.
    Brune K; Katus HA; Moecks J; Spanuth E; Jaffe AS; Giannitsis E
    Clin Chem; 2008 Jul; 54(7):1149-57. PubMed ID: 18451314
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic value of plasma MR-proADM vs NT-proBNP for heart failure in people with type 2 diabetes: the SURDIAGENE prospective study.
    Fraty M; Velho G; Gand E; Fumeron F; Ragot S; Sosner P; Mohammedi K; Gellen B; Saulnier PJ; Halimi JM; Montaigne D; Ducrocq G; Rehman M; Marre M; Roussel R; Hadjadj S;
    Diabetologia; 2018 Dec; 61(12):2643-2653. PubMed ID: 30232509
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.
    Omland T; Sabatine MS; Jablonski KA; Rice MM; Hsia J; Wergeland R; Landaas S; Rouleau JL; Domanski MJ; Hall C; Pfeffer MA; Braunwald E;
    J Am Coll Cardiol; 2007 Jul; 50(3):205-14. PubMed ID: 17631211
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population.
    Neeland IJ; Drazner MH; Berry JD; Ayers CR; deFilippi C; Seliger SL; Nambi V; McGuire DK; Omland T; de Lemos JA
    J Am Coll Cardiol; 2013 Jan; 61(2):187-95. PubMed ID: 23219305
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Degree and distribution of left ventricular hypertrophy as a determining factor for elevated natriuretic peptide levels in patients with hypertrophic cardiomyopathy: insights from cardiac magnetic resonance imaging.
    Park JR; Choi JO; Han HJ; Chang SA; Park SJ; Lee SC; Choe YH; Park SW; Oh JK
    Int J Cardiovasc Imaging; 2012 Apr; 28(4):763-72. PubMed ID: 21516440
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma NT-proBNP is independently associated with albuminuria in type 2 diabetes.
    Zhou L; Cai X; Li M; Han X; Ji L
    J Diabetes Complications; 2016; 30(4):669-74. PubMed ID: 26922580
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association of N-terminal pro-brain natriuretic peptide with the severity of coronary artery disease in patients with normal left ventricular ejection fraction.
    Wu N; Ma F; Guo Y; Li X; Liu J; Qing P; Xu R; Zhu C; Jia Y; Liu G; Dong Q; Jiang L; Li J
    Chin Med J (Engl); 2014; 127(4):627-32. PubMed ID: 24534213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.